Abstract

Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
Arne Östman ... Jonas Bergh
The American Journal of Pathology | VOL. 175
Arne Östman, et. al.Arne Östman ... Jonas Bergh
01 Jul 2009
RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling
Geetanjali Bansal ... Genqing Liang
Journal of Biological Chemistry | VOL. 284
Geetanjali Bansal, et. al.Geetanjali Bansal ... Genqing Liang
01 Aug 2009
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Thompson ... E Senkus
Annals of Oncology | VOL. 24
A Thompson, et. al.A Thompson ... E Senkus
01 Oct 2013
Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger
Eric A Strom ... Thomas A Buchholz
International Journal of Radiation Oncology, Biology, Physics | VOL. 66
Eric A Strom, et. al.Eric A Strom ... Thomas A Buchholz
02 Aug 2006
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers